Nuvation Bio Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Nuvation Bio stock has a consensus rating of "Strong Buy" and an average price target of $12.33. The average 1-year stock price forecast is 112.59% higher than the current stock price, while the lowest is $7.00 (+20.69%) and the highest is $19 (+227.59%).

Price Target: $12.33 (+112.59%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$7.00	$12.33	$12	$19
Change	+20.69%	+112.59%	+106.90%	+227.59%

Analyst Ratings

The average analyst rating for Nuvation Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	7	7	7	7	7	7
Buy	2	2	2	2	2	2
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	10	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $20 → $19	Buy	Maintains	$20 → $19	+227.59%	Jul 7, 2026
David Nierengarten Wedbush	Wedbush	Buy Maintains $11	Buy	Maintains	$11	+89.66%	Jun 30, 2026
Gregory Renza Truist Financial	Truist Financial	Buy Maintains n/a	Buy	Maintains	n/a	n/a	Jun 10, 2026
Yaron Werber TD Cowen	TD Cowen	Buy Reiterates n/a	Buy	Reiterates	n/a	n/a	Jun 1, 2026
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $17	Buy	Reiterates	$17	+193.10%	May 26, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

202.91M

from 62.90M

222.58%

from 62.90M

Revenue Next Year

289.92M

from 202.91M

42.88%

from 202.91M

EPS This Year

-0.28

from -0.49

EPS Next Year

-0.06

from -0.28

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	7.87M	62.90M	202.91M
Revenue Growth	-	-	-	-	698.96%	222.58%
Gross Profit	-	-	-	795.00K	53.60M	185.00M
Gross Margin	-	-	-	10.10%	85.22%	91.17%
Operating Income	-89.53M	-119.73M	-99.82M	-167.56M	-213.06M	-127.19M
Net Income	-86.85M	-104.20M	-75.80M	-567.94M	-204.63M	-115.06M
EPS	-	-	-	-	-0.49	-0.28
Free Cash Flow	-39.03M	-62.44M	-41.59M	-52.19M	-115.78M	-87.92M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	215.5M
Avg	202.9M
Low	181.6M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	242.6%
Avg	222.6%
Low	188.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.28
Avg	-0.28
Low	-0.28

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-